FundedIQ
Biotechnology

BioCurity Pharmaceuticals: Funding, Investors & Team (Oct 2026)

BioCurity Pharmaceuticals is a biopharmaceutical company with a mission to transform a cancer patient’s recovery, by addressing a global unmet need for an effective treatment to mitigate radiation therapy toxicity. It is on track to fundamentally change the course of radiation therapy for cancer patients, worldwide. Approximately 6 million of the 18 million people who will be diagnosed with cancer every year, will receive radiation treatment. The lack of an effective treatment for the adverse side effects associated with radiation therapy represents a substantial market opportunity, but most importantly, a chance to help better the quality of life for cancer survivors around the world. BioCurity’s patented technologies and drugs in their pipeline have the potential to significantly reduce radiation toxicity, not just for newly diagnosed patients, but also for the millions of patients who must receive radiation as a part of their ongoing treatment for cancer.

biocurity.com LinkedIn Jupiter, United States 1-10 employees
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Total raised
$80k
Rounds
1
Latest
Seed
Apr 2022

BioCurity Pharmaceuticals has raised $80k across 1 funding round on record, the most recent a Seed of $80k announced in Apr 2022.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

BioCurity Pharmaceuticals Company Profile and Key Stats

Total funding raised
$80k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$80k in Apr 2022
Employees
1-10
reported band
Headquarters
Jupiter, United States

Latest funding round on record: Apr 2022.

BioCurity Pharmaceuticals Funding Rounds

Date
Round
Amount
Seed
$80k

BioCurity Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Cheryl Baker
Founder
Locked

Contact details for the BioCurity Pharmaceuticals team: 1 of 1 has an email address on file.

Start 14-day free trial →

BioCurity Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
17,153
$3.1M

BioCurity Pharmaceuticals' latest round of $80k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like BioCurity Pharmaceuticals in Biotechnology and Jupiter

Companies Similar to BioCurity Pharmaceuticals

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

BioCurity Pharmaceuticals Funding FAQs

What does BioCurity Pharmaceuticals do?

BioCurity Pharmaceuticals is a biopharmaceutical company with a mission to transform a cancer patient’s recovery, by addressing a global unmet need for an effective treatment to mitigate radiation therapy toxicity. It is on track to fundamentally change the course of radiation therapy for cancer patients, worldwide. Approximately 6 million of the 18 million people who will be diagnosed with cancer every year, will receive radiation treatment. The lack of an effective treatment for the adverse side effects associated with radiation therapy represents a substantial market opportunity, but most importantly, a chance to help better the quality of life for cancer survivors around the world. BioCurity’s patented technologies and drugs in their pipeline have the potential to significantly reduce radiation toxicity, not just for newly diagnosed patients, but also for the millions of patients who must receive radiation as a part of their ongoing treatment for cancer.

How much funding has BioCurity Pharmaceuticals raised?

BioCurity Pharmaceuticals has raised $80k across 1 round on record. The most recent is a Seed of $80k announced in Apr 2022.

When did BioCurity Pharmaceuticals last raise funding?

BioCurity Pharmaceuticals' most recent funding round on record is a Seed of $80k, announced in Apr 2022.

Who founded BioCurity Pharmaceuticals?

FundedIQ lists Cheryl Baker (Founder) at BioCurity Pharmaceuticals.

Where is BioCurity Pharmaceuticals headquartered?

BioCurity Pharmaceuticals is based in Jupiter, Florida, United States.

How many employees does BioCurity Pharmaceuticals have?

BioCurity Pharmaceuticals is in the 1-10 employee band.

How does BioCurity Pharmaceuticals' funding compare to other Biotechnology startups?

BioCurity Pharmaceuticals' latest round of $80k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's BioCurity Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioCurity Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.